Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, Devarshi Vasa, 1 Gustave L. Levy Pl, New York, NY 10029, United States.
Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, Devarshi Vasa, 1 Gustave L. Levy Pl, New York, NY 10029, United States.
J Stroke Cerebrovasc Dis. 2024 Oct;33(10):107911. doi: 10.1016/j.jstrokecerebrovasdis.2024.107911. Epub 2024 Aug 5.
Stress hyperglycemia has been linked to poor outcomes in intracerebral hemorrhage (ICH). Recent studies using the ratio of blood glucose to glycated hemoglobin (HbA1c) as a marker for stress hyperglycemia have demonstrated greater discriminative power in predicting poor outcomes for stroke inpatients compared to blood glucose alone. Therefore, we aimed to investigate whether the preoperative glucose-to-HbA1c ratio is a predictor of postoperative outcomes in patients who have undergone minimally invasive ICH evacuation.
Retrospective chart review was performed on ICH patients treated with minimally invasive surgery (MIS) in a single health system from 2015 to 2022. Stress hyperglycemia was defined as preoperative glucose-to-HbA1c ratio > calculated-median. Postoperative outcomes including modified Rankin Score (mRS) and length of stay (LOS) were collected. Univariate analyses were conducted to determine associations. Variables with p<0.05 were included in multivariate analyses.
Of 192 patients who underwent minimally invasive ICH evacuation and had available glucose data, 96 demonstrated stress hyperglycemia (glucose-to-HbA1c ratio > 1.23). Patients with stress hyperglycemia were more likely to have a history of diabetes (43 % vs. 27 %, p=0.034), IVH (54 % vs. 33 %, p=0.007), higher preoperative hematoma volumes (46.8 ml vs. 38.6 mL, p=0.02), higher postoperative hematoma volumes (6 ml vs. 2.9 mL, p=0.008), smaller evacuation percentages (86.7 % vs. 92.7 %, p=0.048), longer procedure lengths (2.78 hrs vs. 2.23 hrs, p=0.015), and prolonged ICU LOS (9.44 days vs. 5.68 days, p=0.003). In a multivariate analysis, stress hyperglycemia remained predictive of prolonged ICU LOS (OR=2.44; p=0.026) when controlling for initial NIHSS, IVH, time to evacuation, procedure time, and diabetes.
Stress hyperglycemia was strongly associated with prolonged ICU LOS after MIS for ICH. Understanding factors associated with LOS may provide predictive value for a patient's hospital course after minimally invasive ICH evacuation and further guide clinician expectations of recovery.
应激性高血糖与脑出血(ICH)患者的不良预后相关。最近使用血糖与糖化血红蛋白(HbA1c)比值作为应激性高血糖标志物的研究表明,与单独血糖相比,该标志物对预测住院脑卒中患者的不良预后具有更高的判别能力。因此,我们旨在研究微创 ICH 清除术后患者术前血糖与 HbA1c 的比值是否可预测术后结局。
对 2015 年至 2022 年期间在单一医疗系统中接受微创手术(MIS)治疗的 ICH 患者进行回顾性图表审查。应激性高血糖定义为术前血糖与 HbA1c 的比值>计算中位数。收集术后结局,包括改良 Rankin 量表(mRS)和住院时间(LOS)。进行单变量分析以确定关联。p<0.05 的变量被纳入多变量分析。
在 192 例接受微创 ICH 清除术且血糖数据可用的患者中,96 例表现出应激性高血糖(血糖与 HbA1c 的比值>1.23)。应激性高血糖患者更有可能有糖尿病病史(43%比 27%,p=0.034)、IVH(54%比 33%,p=0.007)、较高的术前血肿量(46.8ml 比 38.6ml,p=0.02)、较高的术后血肿量(6ml 比 2.9ml,p=0.008)、较小的清除百分比(86.7%比 92.7%,p=0.048)、较长的手术时间(2.78 小时比 2.23 小时,p=0.015)和延长的 ICU LOS(9.44 天比 5.68 天,p=0.003)。在多变量分析中,当控制初始 NIHSS、IVH、清除时间、手术时间和糖尿病时,应激性高血糖仍然与 ICU LOS 延长相关(OR=2.44;p=0.026)。
应激性高血糖与 MIS 治疗 ICH 后 ICU LOS 延长密切相关。了解与 LOS 相关的因素可能为微创 ICH 清除术后患者的住院病程提供预测价值,并进一步指导临床医生对康复的期望。